Name | Title | Contact Details |
---|
Metro-Med Inc is a Burbank, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Symmetry Surgical is dedicated to developing high-quality surgical instruments that respond to clinicians` needs as they arise, making a real difference in the lives of patients. Our broad portfolio also brings together the rich history and distinctive product lines of the recently acquired stainless steel and titanium surgical instruments of Codman, the surgical instruments of Specialty Surgical Instrumentation (SSI) and the electrosurgery instruments of Olsen Medical. Offering one of the most comprehensive suites of surgical instruments in the industry, we continue to collaborate with clinicians, global medical device manufacturers and thousands of hospitals to provide solutions for today`s needs and tomorrow`s growth. Headquartered just outside of Nashville, TN, Symmetry Surgical is a wholly owned subsidiary of Symmetry Medical Inc.(NYSE:SMA).
CurvaFix is developing implantable products to improve fracture repair in curved bones. The company is focusing on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures. The CurvaFix® IM Implant is the only intramedullary device capable of following the natural bone shape and filling the space within curved bones such as the pelvis.
Lucira Health has developed an at home COVID-19 test kit that delivers PCR quality molecular accuracy in the palm of your hand in 30 minutes or less. Our technology is transforming how we reduce the spread of infectious diseases by bringing accurate, easy-to-use self-testing into the home. This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or revoked sooner.
Labcon North America is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.